Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)
Clinical trial NCT02968901 · TERMINATED
Trial details
- NCT number
- NCT02968901
- Sponsor
- Actelion
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2018-09-10
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.